Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

L.A. McKeown

October 24, 2023

Presentation TCT 2020

ILLUMENATE Trial Update:4-Year ILLUMENATE Global Stellarex DCB Data

Presenter: Andrew Holden

October 18, 2020

News Conference News TCT 2020

IN.PACT BTK Provides Renewed Hope for Attacking CLI With DCBs

L.A. McKeown

October 18, 2020

Presentation TCT 2020

ILLUMENATE: Four-Year Results With a Low-Dose Paclitaxel Drug-Coated Balloon in De Novo And Restenotic Femoropopliteal Lesions

Presenter: Andrew Holden

October 18, 2020

News Opinion Editor's Corner TCT 2020

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

Shelley Wood

October 09, 2020

News Conference News TCT 2019

‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures

L.A. McKeown

September 28, 2019

News Conference News TCT 2016

ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions

L.A. McKeown

November 07, 2016

Presentation TCT 2016

ILLUMENATE U.S.: A Prospective, Randomized Trial of a Paclitaxel-Coated Balloon vs an Uncoated Balloon for Treatment of Diseased Superficial Femoral and Popliteal Arteries

Presenter: Martin B. Leon, Louis A. Cannon, Sean P. Lyden

November 02, 2016

News Opinion Editor's Corner TCT 2016

TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever

Shelley Wood

October 24, 2016

Video

» Interview

Late Breaking Clinical Trial Interview: ILLUMENATE U.S.: Sean P Lyden, MD

May 11, 2018

Video

» Interview

TCT 2016: Dr. C. Michael Gibson talks with Dr. Sean Lyden about ILLUMENATE U.S.

May 11, 2018

Advertisement

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

ILLUMENATE Trial Update:4-Year ILLUMENATE Global Stellarex DCB Data

IN.PACT BTK Provides Renewed Hope for Attacking CLI With DCBs

ILLUMENATE: Four-Year Results With a Low-Dose Paclitaxel Drug-Coated Balloon in De Novo And Restenotic Femoropopliteal Lesions

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures

ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions

ILLUMENATE U.S.: A Prospective, Randomized Trial of a Paclitaxel-Coated Balloon vs an Uncoated Balloon for Treatment of Diseased Superficial Femoral and Popliteal Arteries

TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever

Late Breaking Clinical Trial Interview: ILLUMENATE U.S.: Sean P Lyden, MD

TCT 2016: Dr. C. Michael Gibson talks with Dr. Sean Lyden about ILLUMENATE U.S.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content